BIO KEY INTERNATIONAL INC (BKYI): Nasdaq/NYSE listing notice — BIO-key receives Nasdaq delisting notice; stock to move to OTC Markets on May 13

BIO KEY INTERNATIONAL INC

Nasdaq suspends BKYI trading after close May 12 for failing to maintain $1 bid price for 10 consecutive days by May 4 and late Form 10-K.
Company will request a hearing before a Nasdaq Hearings Panel to appeal delisting; no guarantee of reinstatement.
Stock to be quoted on OTC Markets under symbol BKYI starting May 13; reverse stock split was effective April 30 but timing fell short.
CEO states 1H'26 revenue expected to rise 50% to $5M vs $3.3M in 1H'25; targets profitability vs $1.9M net loss in 1H'25.
Cash position expected to remain in line with year-end 2025 level; company retains listing consultants to expedite Nasdaq return.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

BIO KEY INTERNATIONAL INC received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: delisting notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

May 6, 2026, BIO-key International, Inc. (the “ Company ”) received notice from the staff of The Nasdaq Stock Market, LLC (“ Nasdaq ”) stating that the Company had not regained compliance with Nasdaq Listing Rule 5550(a)

View on SEC.gov

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

BIO KEY INTERNATIONAL INC received a nasdaq delisting notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: delisting notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

May 6, 2026, BIO-key International, Inc. (the “ Company ”) received notice from the staff of The Nasdaq Stock Market, LLC (“ Nasdaq ”) stating that the Company had not regained compliance with Nasdaq Listing Rule 5550(a)

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

BIO KEY INTERNATIONAL INC filing history →

Source: SEC EDGAR

accession 0001437749-26-016455

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.